News

PMLive16h
FDA approves Fujirebio’s Lumipulse as first Alzheimer’s disease blood test
The US Food and Drug Administration (FDA) has approved Fujirebio Diagnostics’ Alzheimer’s disease (AD) blood test to help ...
Global Alzheimer’s Platform Foundation Applauds FDA Authorization of the First Blood-Based Diagnostic Test for Assessing Alzheimer’s Disease
The Global Alzheimer’s Platform Foundation® (GAP) applauds the FDA's clearance of the first blood test to diagnose ...
Everyday Health on MSN7h
First Blood Test to Diagnose Alzheimer’s Cleared by FDA
The Lumipulse blood test identifies the presence of amyloid plaques, a hallmark of Alzheimer’s disease that impairs normal brain function.
The Scientist13h
Fujirebio Receives Marketing Clearance for Lumipulse® G pTau 217/ β-Amyloid 1-42 Plasma Ratio In-Vitro Diagnostic Test
Fujirebio today announced that the U.S. Food and Drug Administration (FDA) has granted 510(k) clearance for the company’s ...
New Atlas18h
Breakthrough Alzheimer's blood test has been approved for the US
The very first blood test for Alzheimer's disease detection has been green-lit by the US Food and Drug Administration (FDA), ...
Discover Magazine on MSN6h
Alzheimer’s Disease Blood Test Could Lead to Earlier, More Effective Treatment
Since Alzheimer's disease affects over 7 million people in the U.S., potentially doubling to 14 million by 2050, earlier ...
FDA approves first blood test to detect Alzheimer’s, marking major breakthrough
Experts say the test could dramatically improve access to earlier, more accurate diagnoses, particularly for older Americans ...
Onlymyhealth17h
FDA Approves First-Ever Blood Test for Early Alzheimer’s Detection, Replacing Invasive Brain Scans
The FDA has approved the first blood test to detect early Alzheimer’s replacing invasive scans Learn how this game-changing tool could transform diagnosis and treatment ...